Compares nivolumab, ipilimumab plus radiotherapy versus nivolumab and ipilimumab for advanced esophageal cancer, indicating potential treatment benefits.
This trial has been registered on November 5th, 2024, in the Japan Registry of Clinical Trials as jRCT1031240461 (https://jrct.mhlw.go.jp/en-latest-detail/jRCT1031240461).
No takes yet. Share an insight, caveat, or question.
Tsushima et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: